Add Yahoo as a preferred source to see more of our stories on Google. CMR Surgical is based in Cambridge, United Kingdom. (Courtesy of CMR Surgical) This story was originally published on MedTech Dive ...

Add Yahoo as a preferred source to see more of our stories on Google. CMR plans to begin US commercial activities for its Versius robots in 2026. Image credit: T. Schneider via Shutterstock.com. (T.

A pioneering study at King's College London, University of Oxford and Guy's and St Thomas' NHS Foundation Trust has successfully tested a new robotic surgical system for treating head and neck ...

CMR Surgical launches vLimeLite * a new imaging technology to visualise ICG, the first product launch in a series of 2024 product releases as part of Versius Plus, a significant enhancement to the ...

CMR Surgical Ltd. hopes to soon gain U.S. FDA 510(k) clearance for its Versius Plus surgical robotic system to bring it to the U.S. market amid rising demand for robotic surgery. Although the ...

CMR Surgical is launching a new imaging technology to help users of its Versius robot visualize the flow of blood through organs during a procedure. The company’s vLimeLite add-on incorporates a ...

CMR, among other surgical robotics companies, is providing surgical data Nvidia’s Open-H dataset will use to train next-gen ...

Cambridge, England-based CMR Surgical said it has received FDA 510(k) clearance for Versius Plus, its second-generation surgical robotic platform. The clearance covers cholecystectomy procedures, also ...

CMR Surgical has secured US Food and Drug Administration (FDA) clearance for its Versius Plus minimally invasive robotic surgical system, priming the company to go ahead with US commercialisation ...